Racial and gender-based differences in COVID-19
The novel coronavirus disease (COVID-19) has become a global health crisis since its first
appearance in Wuhan, China. Current epidemiological studies suggest that COVID-19 …
appearance in Wuhan, China. Current epidemiological studies suggest that COVID-19 …
Pulmonary and extra-pulmonary clinical manifestations of COVID-19
KD Johnson, C Harris, JK Cain, C Hummer… - Frontiers in …, 2020 - frontiersin.org
The severe acute respiratory syndrome coronavirus− 2 (SARS-CoV-2) has been recently
identified as the culprit of the highly infectious, outbreak named coronavirus disease 2019 …
identified as the culprit of the highly infectious, outbreak named coronavirus disease 2019 …
COVID-19 presenting as acute pancreatitis
MM Aloysius, A Thatti, A Gupta, N Sharma, P Bansal… - Pancreatology, 2020 - Elsevier
The ongoing pandemic of Coronavirus disease-2019 (COVID-19) has spread over 200
countries worldwide, affecting> 2 million people and> 120,000 deaths. COVID-19 is caused …
countries worldwide, affecting> 2 million people and> 120,000 deaths. COVID-19 is caused …
Non-respiratory presentations of COVID-19, a clinical review
M AlSamman, A Caggiula, S Ganguli, M Misak… - The American journal of …, 2020 - Elsevier
Introduction Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19)
is a highly infectious viral syndrome currently threatening millions of people worldwide. It is …
is a highly infectious viral syndrome currently threatening millions of people worldwide. It is …
Gastrointestinal symptoms and outcomes in hospitalized coronavirus disease 2019 patients
P Ramachandran, I Onukogu, S Ghanta… - Digestive …, 2020 - karger.com
Introduction: Gastrointestinal (GI) symptoms are increasingly being recognized in
coronavirus disease 2019 (COVID-19). It is unclear if the presence of GI symptoms is …
coronavirus disease 2019 (COVID-19). It is unclear if the presence of GI symptoms is …
[HTML][HTML] Coronavirus disease (COVID-19) caused by (SARS-CoV-2) infections: a real challenge for human gut microbiota
The current COVID-19 pandemic is a great challenge for worldwide researchers in the
human microbiota area because the mechanisms and long-term effects of the infection at the …
human microbiota area because the mechanisms and long-term effects of the infection at the …
Characteristics of viral shedding time in SARS-CoV-2 infections: a systematic review and meta-analysis
D Yan, X Zhang, C Chen, D Jiang, X Liu… - Frontiers in public …, 2021 - frontiersin.org
Background: The viral shedding time (VST) of SARS-CoV-2 mainly determines its
transmission and duration of infectiousness. However, it was heterogeneous in the existing …
transmission and duration of infectiousness. However, it was heterogeneous in the existing …
[HTML][HTML] Addition of tocilizumab to the standard of care reduces mortality in severe COVID-19: a systematic review and meta-analysis
U Boregowda, A Perisetti, A Nanjappa… - Frontiers in …, 2020 - frontiersin.org
Introduction: Tocilizumab (TCZ) is an anti-interleukin-6 antibody that has been used for the
treatment of severe coronavirus disease 2019 (COVID-19). However, concrete evidence of …
treatment of severe coronavirus disease 2019 (COVID-19). However, concrete evidence of …
COVID-19 extrapulmonary illness–special gastrointestinal and hepatic considerations
Coronaviruses have caused three global outbreaks in the last 20 years, which include
Severe Acute Respiratory Syndrome (SARS) caused by SARS-CoV (SARS-CoV-1), Middle …
Severe Acute Respiratory Syndrome (SARS) caused by SARS-CoV (SARS-CoV-1), Middle …
[HTML][HTML] Clinical characteristics, diagnosis, and treatment of major coronavirus outbreaks
Human coronavirus infections have been known to cause mild respiratory illness. It changed
in the last two decades as three global outbreaks by coronaviruses led to significant …
in the last two decades as three global outbreaks by coronaviruses led to significant …